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ABSTRACT 
In 2013-2014, Tanzania embarked on a major revamp of the 
management of its public health supply chains for medicines and 
other health supplies. These upgrades include the establishment of 
a national electronic logistics management information system 
(eLMIS) and the introduction of a Logistics Management Unit 
(LMU) to use the eLMIS for managing all key public health 
commodities. This paper describes results from the “round one” 
evaluation of the impact of those key management upgrades 
roughly one year after their introduction. The study has three main 
components: (1) analysis of reporting, data use, management 
practices, and supply chain outcomes; (2) a cost and cost-
effectiveness analysis and (3) a return on investment analysis to 
measure savings generated by the new systems. The study used a 
non-experimental pre- and post-design to compare the previous 
system with the upgraded management system. The quantitative 
analysis found that stock out rates for all product goods dropped 
from 32% to 23%, with the frequency of stock-outs greater than 7 
days dropping from 24% to 15%. Annual supply chain costs 
increased from $66million to $76million. Performance improved 
from the 2014 baseline findings of 68% to 77%, but cost per value 
of commodities adjusted for performance decreased from 58% at 
baseline to 50% in year 1. 
1.INTRODUCTION 
In late 2013, Tanzania invested $3.3 million in two key 
interventions as a major revamp of its public health supply chain 
management for medicines and other health supplies. The 
enhancements included introducing a national, electronic logistics 
management information system (eLMIS) for managing 
pharmaceutical distribution, and establishing a Logistics 
Management Unit (LMU) to use the eLMIS data for oversight and 
performance improvements. Because this investment represents a 
significant financial commitment to the public health supply 
chain, a baseline study was undertaken in 2013 and a further 
analysis in 2015 to evaluate the supply chain performance, cost, 
and cost-effectiveness of these management upgrades and return 
on investment on the current system. In addition to providing 
economic and performance data on supply chain management 
practices, the analysis carried out also points to areas where these 
interventions could provide improved supply chain efficiency and 
generate cost savings. 
Development projects must demonstrate real impact and 
measurable results in order to evaluate the value in financing these 
initiatives. This study helps answer a fundamental question that 
ministries of health and donors, alike, are now asking: With 
limited funding, what management and technology investments 
can be cost-effective and have a transformative effect on the 
performance of the supply chain for medicines, vaccines, and 
other health commodities? Results of this study will provide 
evidence to inform efforts in other countries seeking to implement 
similar interventions.    
The study had two main components: (1) a baseline and year 1 
collection of performance information including supply chain 
reporting, data use, management practice, and outcomes; and (2) a 
cost study to provide input for cost-effectiveness analysis.  Data 
collection for the initial analysis of the supply chain took place 
between August and October 2013 and year 1 data collection took 
place between April and May 2015. Data came from a range of 
special surveys applied at different levels of the supply chain, as 
well as from existing databases. Cost and performance elements 
were added to existing quarterly surveys and were collected from 
a nationally representative sample of 220 health facilities. The 
evaluation analyzed results related to three major logistics 
systems, which handle the vast majority of products in Tanzania: 
the Integrated Logistics System (ILS), through which essential 
medicines are managed; the antiretroviral drugs (ARV) logistics 
system; and the expanded program on immunization (EPI), which 
manages vaccines. ILS data was segmented to allow analysis of 
Family Planning and Malaria product groups.  
2.DEVELOPMENT IMPACT  
As in many other developing countries, the management of the 
public health supply chain in Tanzania evolved along product 
lines associated with specific public health programs. The result 
was a fragmented, uncoordinated management system with 
separate structures for HIV, TB, vaccines, essential drugs, and 
contraceptives. A key management function—information 
management—evolved along product groupings. These separate, 
and largely paper-based logistics management information 
systems (LMIS), did not generate accurate, quality, and timely 
data. The lack of data visibility contributed to poor system 
performance that raised costs, hampered stock availability, and 
made it harder to serve the millions of Tanzanians who rely on 
public health facilities. 
To address these problems, the Ministry of Health Community 
Development Gender Elderly and Children (MOHCDGEC) set up 
the LMU, a management structure responsible for coordinating, 
monitoring, and supporting all of the logistics activities for 
various commodity groups. LMU staff identify supply chain 
bottle-necks, develop solutions for those challenges, and 
implement corresponding interventions. Following the 
implementation of the LMU, the MOHCDGEC facilitated the Bloomberg Data for Good Exchange Conference. 25-Sep-2016, New York City, NY, USA. 
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rollout of a nationwide eLMIS to consolidate existing electronic 
and paper-based systems; such consolidation is a challenge faced 
by many developing nations. The eLMIS is expected to improve 
data visibility by providing accurate, quality, and timely data. The 
LMU will be responsible for actively managing, analyzing and 
using data generated from the eLMIS. 
The MOHCDGEC and other stakeholders also wanted to 
understand the cost-effectiveness of the current system and what 
portions of the system might see cost savings and performance 
improvements after the LMU and eLMIS interventions.  
2.1.RESULTS 
From the quantitative analysis that was conducted, stock out 
rates—defined as zero availability of a given product at the point 
of service—on average across all product groups dropped from 
32% to 23%, with the frequency of stock-outs greater than 7 days 
dropping from 24% to 15%. Appropriate inventory levels at health 
facilities increased slightly from 18% to 20%, indicating that 
increases in stock availability do not appear to be a result of 
overstocking.  
 
 
Figure 1: Facilities stocked out on day of visit 
 
The levels of expiries at the facility also improved, decreasing by 
0.1-0.4%. With respect to cost data, the annual cost of the supply 
chain increased from $66million to $76million. The throughput of 
the supply chain also increased from $168million to $197million. 
Despite this increase in costs and throughput, performance of the 
supply chain improved from the 2014 baseline findings of 68% to 
77%. The cost per value of commodities adjusted for performance 
shows a decrease from 58% at baseline to 50% in year 1. A time-
series analysis drawing on three years of quarterly data also found 
statistically significant positive changes in these performance 
indicators.  
   
INTERPRETATION AND 
RECOMMENDATION 
Findings from the year 1 data collection indicate that the 
information and management upgrades had a positive impact on 
key supply outcomes, especially stock availability. Both the 
incidence and the duration of stock-outs decreased, while 
inventory levels remained relatively constant. While the upgraded 
supply chain system costs were higher, initial results indicate that 
it is operating more efficiently; the implementation of the LMU 
and eLMIS reduced overall expiry rates, resulting in savings due 
to lower wastage. Moreover, these management upgrades also 
appear to have generated significant savings to the government 
despite the supply chain challenges that the country experienced 
at the same time.  
It is however important to note that while performance and cost 
data are generally supportive and justify the level of investment to 
improve the supply chain, many of the gains noted may be fragile. 
For example, there was little movement in some management 
practice indicators between baseline and round 1 data collection. 
As such, it will be important to conduct further data collection 
surveys to discern the true impact and performance, cost and cost-
benefit of these interventions.  
3.CONCLUSION 
The improved visibility of supply chain data provided by the 
eLMIS was a critical step to improving performance and reducing 
costs. However, technology-driven data visibility alone is 
insufficient. For real change to happen, the data must be analyzed 
and used for routine and strategic decisions and for continuous 
quality improvement. The LMU established the core team of 
dedicated data users who have the mandate to analyze supply 
chain data and affect change. 
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